CANTATORE, FRANCESCO PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 18.677
EU - Europa 11.298
AS - Asia 8.228
SA - Sud America 1.448
Continente sconosciuto - Info sul continente non disponibili 1.152
AF - Africa 147
OC - Oceania 23
Totale 40.973
Nazione #
US - Stati Uniti d'America 18.331
CN - Cina 3.131
IE - Irlanda 3.085
SG - Singapore 2.642
UA - Ucraina 2.121
RU - Federazione Russa 1.790
SE - Svezia 1.376
BR - Brasile 1.193
HK - Hong Kong 855
FR - Francia 672
IT - Italia 575
DE - Germania 548
VN - Vietnam 475
FI - Finlandia 410
IN - India 304
GB - Regno Unito 300
TR - Turchia 296
BD - Bangladesh 156
CA - Canada 148
CZ - Repubblica Ceca 118
AR - Argentina 99
MX - Messico 66
IQ - Iraq 63
PL - Polonia 55
EC - Ecuador 47
NL - Olanda 45
ID - Indonesia 44
AT - Austria 41
JP - Giappone 38
ZA - Sudafrica 37
BE - Belgio 33
ES - Italia 26
UZ - Uzbekistan 25
CO - Colombia 24
PK - Pakistan 24
CR - Costa Rica 21
JM - Giamaica 21
EG - Egitto 20
PH - Filippine 20
VE - Venezuela 20
CL - Cile 19
EU - Europa 19
MA - Marocco 18
JO - Giordania 16
PY - Paraguay 16
SA - Arabia Saudita 16
TT - Trinidad e Tobago 15
AZ - Azerbaigian 14
LT - Lituania 14
PE - Perù 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
KE - Kenya 13
PT - Portogallo 13
HN - Honduras 12
GP - Guadalupe 11
RO - Romania 11
PR - Porto Rico 10
DK - Danimarca 9
DZ - Algeria 9
NP - Nepal 9
NZ - Nuova Zelanda 9
UY - Uruguay 9
IL - Israele 8
MY - Malesia 8
SV - El Salvador 8
CH - Svizzera 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
CI - Costa d'Avorio 6
GT - Guatemala 6
HR - Croazia 6
KZ - Kazakistan 6
NG - Nigeria 6
NI - Nicaragua 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
AL - Albania 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
LV - Lettonia 4
MD - Moldavia 4
PS - Palestinian Territory 4
SC - Seychelles 4
TH - Thailandia 4
AO - Angola 3
BG - Bulgaria 3
Totale 39.798
Città #
Dublin 3.081
San Jose 2.731
Dallas 1.851
Jacksonville 1.425
Chandler 1.330
Singapore 1.231
Ashburn 1.175
Dearborn 985
Nyköping 880
Hong Kong 845
Nanjing 650
Beijing 639
Santa Clara 475
Council Bluffs 398
Lauterbourg 344
Wilmington 340
Princeton 331
Columbus 330
Munich 278
San Mateo 224
New York 220
Nanchang 210
Moscow 207
Los Angeles 203
The Dalles 186
Helsinki 175
Ho Chi Minh City 166
Shenyang 148
Boardman 142
Ann Arbor 121
Hebei 113
Phoenix 111
Des Moines 108
São Paulo 103
Jiaxing 102
Brno 97
Tianjin 96
Kunming 91
Woodbridge 91
Hanoi 85
Changsha 75
Shanghai 73
Foggia 70
Atlanta 62
Buffalo 56
Chicago 54
Guangzhou 53
North Bergen 52
Seattle 52
Hangzhou 49
London 47
Agrolândia 46
Zhengzhou 46
Milan 45
Frankfurt am Main 44
Orem 44
Jinan 42
Nuremberg 41
San Francisco 41
Brooklyn 39
Dong Ket 34
Hilden 32
Long Beach 32
Warsaw 31
Montreal 30
Ningbo 29
Rome 29
Tokyo 29
Toronto 29
Baghdad 28
Norwalk 28
Brussels 27
Hillsboro 27
Rio de Janeiro 27
Taizhou 27
Fresno 26
Washington 26
Lanzhou 25
Chennai 24
Curitiba 24
Stevenage 24
Guayaquil 23
Philadelphia 23
Turku 23
Bari 22
Pune 22
Boston 21
Tashkent 21
Amsterdam 20
Assago 20
Auburn Hills 20
Changchun 20
Da Nang 20
Falkenstein 20
Haiphong 20
Hanover 20
Manchester 20
Naples 20
Hefei 19
Hudson 19
Totale 24.330
Nome #
Serious spondylodiscitis, septic sacroiliitis and multiple abscesses after ozone therapy for low back pain: A case report on good response to combined treatment with empiric antibiotic and neridronate 1.097
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 563
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 497
Visceral fat dysfunctions in the rat social isolation model of psychosis 276
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 229
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 213
A case of rhupus treated with filgotinib: A promising therapeutic perspective 211
25-Hydroxycholecalciferol in experimental osteoporosis 181
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 168
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 167
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 166
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 165
Chronic psychosocial stress impairs bone homeostasis: A study in the social isolation reared rat 163
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort 163
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 162
Extra-skeletal effects of bisphosphonates. 160
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 160
Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells 160
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 157
Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts 157
A case of chondrodysplasia.Dolichomelic spondylo-epiphyseal chondrodysplasia 154
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 153
Adult Scheuermann's disease as cause of mechanic dorsalgia 152
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 152
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 150
Anti-TNF-α and risk of infections: the experience in one center. 148
Ulcerative colitis and systemic lupus erythematosus. Minerva Med 147
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 146
Normal serum concentrations of 1,25 dihydroxyvitamin D in osteoporosis 145
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 144
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 142
SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS IN ITALIAN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM MULTICENTER GIRRCS (GRUPPO ITALIANO DI RICERCA IN REUMATOLOGIA CLINICA E SPERIMENTALE) STUDY 141
Corticosteroids, a review. 138
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) 138
Effects of anabolic steroids, salmon calcitonin and 25OH-D3 on rat bones 138
Clodronate inhibits angiogenesis in vitro and in vivo 137
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 137
Bisphosphonates: effects on osteoblast. 136
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 136
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 135
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 135
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 135
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 134
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 133
Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3 132
Linear bone densitometry by monochromatic photon absorptiometry. A study of a normal population in Apulia 132
Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause 131
Beta-2 microglobulin in osteoarthrosis 131
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 131
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 131
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 131
Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis 130
Bisphosphonates and osteoarthritis 130
IgA nephropathy in systemic lupus erythematosus. 129
Evaluation of mineral metabolism and bone turnover in osteoporotic females treated withphosphorus and salmon calcitonin 129
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 129
Bone effects of biologic drugs in rheumatoid arthritis. 129
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 129
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 128
A sequential treatment of osteoporosis with anabolic steroids and salmon calcitonin 127
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms 127
Post biliopancreatic by-pass arthritis dermatitis syndrome 126
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 126
Serum 25(OH)D3 in theApulian population (Southern Italy). Epidemiologic study 126
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 125
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 125
Echographic study of Tietze's syndrome. 124
Monitoring biological action of rapamycin in renal transplantation. 124
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis. 124
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 124
Mitochondrial disease mimicking polymyositis: a case report 123
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 123
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 123
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 123
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 123
BIOLOGIC THERAPIES AND INFECTIONS IN THE DAILY PRACTICE: A STUDY ON HISTORICAL COHORT FROM 3 ITALIAN RHEUMATOLOGIC UNITS 123
Neridronate inhibits angiogenesis in vitro and in vivo. 122
C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. 122
La coxalgia 122
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 122
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 122
Vitamin D and the immune system 121
Effect of calcitonin or the anabolic steroid decadurabolin on serum B2 microglobulin in osteoporotic post menopausal women 121
Effects of nandrolonedecanoate on plasma calcitonin, parathormone and vitamin D, in elderly women 121
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 121
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 121
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 121
Fascite eosinofila: entità clinica a se stante o variante clinica della sclerosi sistemica? 120
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 120
AB0253 BIOMARKERS OF CLINICAL RESPONSE TO IL6-R BLOCKADE IN DMARDS INCOMPLETE RESPONDERS (AR-BIOM TRIAL): IL23 AND BAFF AS BIOLOGICAL TARGETS, AND ALBUMIN AS BIOLOGICAL PREDICTOR 120
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 119
Osteocalcin: Skeletal and extra-skeletal effects 119
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. 118
Serum osteocalcin levels in normal humans of different sex and age. An epidemiological study. 118
Osteocytes: central conductors of bone biology in normal and pathological conditions 118
Systemic effects of Wnt signaling 118
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 118
AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea 118
Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 117
Effects of anabolic steroids, 1.25(OH)D3 and calcitonin on osteocalcin and calciotropic hormones 117
Totale 15.565
Categoria #
all - tutte 217.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 217.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.351 0 0 0 10 123 35 45 141 250 222 93 432
2022/20236.944 630 249 282 364 352 632 34 506 3.515 68 150 162
2023/20241.175 179 60 66 51 79 278 23 50 15 47 27 300
2024/20255.508 305 51 118 188 184 824 611 401 1.458 371 482 515
2025/202611.449 578 997 2.285 1.329 463 492 2.195 1.041 816 673 287 293
2026/20274.244 1.189 892 845 1.318 0 0 0 0 0 0 0 0
Totale 40.973